Three-dimensional structure of interleukin 8 in solution - PubMed (original) (raw)
. 1990 Feb 20;29(7):1689-96.
doi: 10.1021/bi00459a004.
Affiliations
- PMID: 2184886
- DOI: 10.1021/bi00459a004
Three-dimensional structure of interleukin 8 in solution
G M Clore et al. Biochemistry. 1990.
Abstract
The solution structure of the interleukin 8 (IL-8) dimer has been solved by nuclear magnetic resonance (NMR) spectroscopy and hybrid distance geometry-dynamical simulated annealing calculations. The structure determination is based on a total of 1880 experimental distance restraints (of which 82 are intersubunit) and 362 torsion angle restraints (comprising phi, psi, and chi 1 torsion angles). A total of 30 simulated annealing structures were calculated, and the atomic rms distribution about the mean coordinate positions (excluding residues 1-5 of each subunit) is 0.41 +/- 0.08 A for the backbone atoms and 0.90 +/- 0.08 A for all atoms. The three-dimensional solution structure of the IL-8 dimer reveals a structural motif in which two symmetry-related antiparallel alpha-helices, approximately 24 A long and separated by about 14 A, lie on top of a six-stranded antiparallel beta-sheet platform derived from two three-stranded Greek keys, one from each monomer unit. The general architecture is similar to that of the alpha 1/alpha 2 domains of the human class I histocompatibility antigen HLA-A2. It is suggested that the two alpha-helices form the binding site for the cellular receptor and that the specificity of IL-8, as well as that of a number of related proteins involved in cell-specific chemotaxis, mediation of cell growth, and the inflammatory response, is achieved by the distinct distribution of charged and polar residues at the surface of the helices.
Similar articles
- The solution structure of melanoma growth stimulating activity.
Fairbrother WJ, Reilly D, Colby TJ, Hesselgesser J, Horuk R. Fairbrother WJ, et al. J Mol Biol. 1994 Sep 23;242(3):252-70. doi: 10.1006/jmbi.1994.1577. J Mol Biol. 1994. PMID: 8089846 - The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.
Powers R, Garrett DS, March CJ, Frieden EA, Gronenborn AM, Clore GM. Powers R, et al. Biochemistry. 1993 Jul 6;32(26):6744-62. doi: 10.1021/bi00077a030. Biochemistry. 1993. PMID: 8329398 - High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy.
Clore GM, Wingfield PT, Gronenborn AM. Clore GM, et al. Biochemistry. 1991 Mar 5;30(9):2315-23. doi: 10.1021/bi00223a005. Biochemistry. 1991. PMID: 2001363 - Three-dimensional structures of alpha and beta chemokines.
Clore GM, Gronenborn AM. Clore GM, et al. FASEB J. 1995 Jan;9(1):57-62. doi: 10.1096/fasebj.9.1.7821760. FASEB J. 1995. PMID: 7821760 Review.
Cited by
- Heterologous Interactions with Galectins and Chemokines and Their Functional Consequences.
Mayo KH. Mayo KH. Int J Mol Sci. 2023 Sep 14;24(18):14083. doi: 10.3390/ijms241814083. Int J Mol Sci. 2023. PMID: 37762385 Free PMC article. Review. - Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview.
Matsushima K, Shichino S, Ueha S. Matsushima K, et al. Proc Jpn Acad Ser B Phys Biol Sci. 2023;99(7):213-226. doi: 10.2183/pjab.99.014. Proc Jpn Acad Ser B Phys Biol Sci. 2023. PMID: 37518010 Free PMC article. Review. - Structural basis of CXC chemokine receptor 1 ligand binding and activation.
Ishimoto N, Park JH, Kawakami K, Tajiri M, Mizutani K, Akashi S, Tame JRH, Inoue A, Park SY. Ishimoto N, et al. Nat Commun. 2023 Jul 11;14(1):4107. doi: 10.1038/s41467-023-39799-2. Nat Commun. 2023. PMID: 37433790 Free PMC article. - Efficient production of fluorophore-labeled CC chemokines for biophysical studies using recombinant enterokinase and recombinant sortase.
Guan W, Zhang N, Bains A, Sadqi M, Dupureur CM, LiWang PJ. Guan W, et al. Biopolymers. 2024 Mar;115(2):e23557. doi: 10.1002/bip.23557. Epub 2023 Jun 21. Biopolymers. 2024. PMID: 37341434 - Therapeutic inhibition of CXCR1/2: where do we stand?
Sitaru S, Budke A, Bertini R, Sperandio M. Sitaru S, et al. Intern Emerg Med. 2023 Sep;18(6):1647-1664. doi: 10.1007/s11739-023-03309-5. Epub 2023 May 30. Intern Emerg Med. 2023. PMID: 37249756 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials